Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Jun;59(6):844–847. doi: 10.1038/bjc.1989.180

Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation.

V Combaret 1, M C Favrot 1, B Kremens 1, I Philip 1, C Bailly 1, B Fontaniere 1, O Gentilhomme 1, F Chauvin 1, J M Zucker 1, J L Bernard 1, et al.
PMCID: PMC2246735  PMID: 2660896

Abstract

In about 50% of patients with stage IV neuroblastoma, micrometastases are present in the bone marrow when it is harvested for an autograft to follow induction therapy, and the risk of graft contamination by neuroblastoma cells has been the rationale for the use of a purging procedure. However, bone marrow metastases are detected with trephine biopsies which only explore the sites biopsied and do not reflect potential contamination of the pooled marrow harvested for autograft. A two-colour fluorochrome labelling method is described which permits as few as 1 neuroblastoma cell in 100,000 normal bone marrow cells from the autograft to be detected. Three monoclonal antibodies (UJ13A, H11 and 11.14) which react with neuroblastoma cells are used as single reagent in combination with a fourth anti-panleucocyte antibody. This method requires only 2 h for the analysis of three million marrow cells from the autograft, and is more effective than alkaline phosphatase staining with the same monoclonal antibodies. Results were compared with conventional techniques (four biopsies and four aspirates) carried out at the same time in 34 consecutive patients. Of 18 cases with negative aspirates and biopsies, neuroblastoma cells were detected in two autografts by the immunological method. Of 16 cases with positive aspirates and/or biopsies, 10 autografts were positive by the immunological method and six were negative. Thus, marrow micrometastases were detected in 16 of the 34 patients, but the autograft contained malignant cells in only 12 of these patients and the immunological analysis demonstrated that the use of a purging procedure allowed the elimination of neuroblastoma cells from the autograft before its reinjection to the patients.

Full text

PDF
844

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan P. M., Garson J. A., Harper E. I., Asser U., Coakham H. B., Brownell B., Kemshead J. T. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer. 1983 May 15;31(5):591–598. doi: 10.1002/ijc.2910310510. [DOI] [PubMed] [Google Scholar]
  2. August C. S., Serota F. T., Koch P. A., Burkey E., Schlesinger H., Elkins W. L., Evans A. E., D'Angio G. J. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. J Clin Oncol. 1984 Jun;2(6):609–616. doi: 10.1200/JCO.1984.2.6.609. [DOI] [PubMed] [Google Scholar]
  3. Bostrom B., Nesbit M. E., Jr, Brunning R. D. The value of bone marrow trephine biopsy in the diagnosis of metastatic neuroblastoma. Am J Pediatr Hematol Oncol. 1985 Fall;7(3):303–305. [PubMed] [Google Scholar]
  4. Cheung N. K., Von Hoff D. D., Strandjord S. E., Coccia P. F. Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies. J Clin Oncol. 1986 Mar;4(3):363–369. doi: 10.1200/JCO.1986.4.3.363. [DOI] [PubMed] [Google Scholar]
  5. Combaret V., Kremens B., Favrot M. C., Laurent J. C., Philip T. S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograft. Bone Marrow Transplant. 1988 May;3(3):221–227. [PubMed] [Google Scholar]
  6. D'Angio G. J., August C., Elkins W., Evans A. E., Seeger R., Lenarsky C., Feig S., Wells J., Ramsay N., Kim T. Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study. Prog Clin Biol Res. 1985;175:557–563. [PubMed] [Google Scholar]
  7. Evans A. E., Griffin G. C., Tartaglione M., Kennett R. H. A method of detecting neuroblastoma in human bone marrow by means of two monoclonal antibodies PI 153/3 and KE2. Hybridoma. 1985 Winter;4(4):289–296. doi: 10.1089/hyb.1985.4.289. [DOI] [PubMed] [Google Scholar]
  8. Favrot M. C., Frappaz D., Maritaz O., Philip I., Fontaniere B., Gentilhomme O., Bailly C., Zucker J. M., Gentet J. C., Kemshead J. Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow. Br J Cancer. 1986 Oct;54(4):637–641. doi: 10.1038/bjc.1986.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Favrot M. C., Hervé P. Detection of minimal malignant cell infiltration in the bone marrow of patients with solid tumours, non-Hodgkin lymphomas and leukaemias. Bone Marrow Transplant. 1987 Aug;2(2):117–122. [PubMed] [Google Scholar]
  10. Favrot M., Philip I., Combaret V., Maritaz O., Philip T. Experimental evaluation of an immunomagnetic bone marrow purging procedure using the Burkitt lymphoma model. Bone Marrow Transplant. 1987 Jun;2(1):59–66. [PubMed] [Google Scholar]
  11. Franklin I. M., Pritchard J. Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies. J Clin Pathol. 1983 Nov;36(11):1215–1218. doi: 10.1136/jcp.36.11.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Graham-Pole J., Lazarus H. M., Herzig R. H., Gross S., Coccia P., Weiner R., Strandjord S. High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma. Am J Pediatr Hematol Oncol. 1984 Spring;6(1):17–26. [PubMed] [Google Scholar]
  13. Hartmann O., Benhamou E., Beaujean F., Kalifa C., Lejars O., Patte C., Behard C., Flamant F., Thyss A., Deville A. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J Clin Oncol. 1987 Aug;5(8):1205–1211. doi: 10.1200/JCO.1987.5.8.1205. [DOI] [PubMed] [Google Scholar]
  14. Hercend T., Reinherz E. L., Meuer S., Schlossman S. F., Ritz J. Phenotypic and functional heterogeneity of human cloned natural killer cell lines. Nature. 1983 Jan 13;301(5896):158–160. doi: 10.1038/301158a0. [DOI] [PubMed] [Google Scholar]
  15. Hunter R. F., Broadway P., Sun S. L., Niell H. B., Mauer A. M. Detection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation. Cancer Res. 1987 May 15;47(10):2737–2740. [PubMed] [Google Scholar]
  16. Kemshead J. T., Goldman A., Fritschy J., Malpas J. S., Pritchard J. Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders. Lancet. 1983 Jan 1;1(8314-5):12–15. doi: 10.1016/s0140-6736(83)91559-3. [DOI] [PubMed] [Google Scholar]
  17. Maritaz O., Combaret V., Favrot M. C. Intérêt de l'analyse immunologique pour la détection de neuroblastes résiduels dans la moelle osseuse. Pathol Biol (Paris) 1988 Jan;36(1):21–24. [PubMed] [Google Scholar]
  18. Philip T., Bernard J. L., Zucker J. M., Pinkerton R., Lutz P., Bordigoni P., Plouvier E., Robert A., Carton R., Philippe N. High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age. J Clin Oncol. 1987 Feb;5(2):266–271. doi: 10.1200/JCO.1987.5.2.266. [DOI] [PubMed] [Google Scholar]
  19. Philip T., Ghalie R., Pinkerton R., Zucker J. M., Bernard J. L., Leverger G., Hartmann O. A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique. J Clin Oncol. 1987 Jun;5(6):941–950. doi: 10.1200/JCO.1987.5.6.941. [DOI] [PubMed] [Google Scholar]
  20. Pritchard J., McElwain T. J., Graham-Pole J. High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer. 1982 Jan;45(1):86–94. doi: 10.1038/bjc.1982.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Treleaven J. G., Gibson F. M., Ugelstad J., Rembaum A., Philip T., Caine G. D., Kemshead J. T. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet. 1984 Jan 14;1(8368):70–73. doi: 10.1016/s0140-6736(84)90004-7. [DOI] [PubMed] [Google Scholar]
  22. Warnke R. A., Gatter K. C., Falini B., Hildreth P., Woolston R. E., Pulford K., Cordell J. L., Cohen B., De Wolf-Peeters C., Mason D. Y. Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med. 1983 Nov 24;309(21):1275–1281. doi: 10.1056/NEJM198311243092102. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES